We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protocols Cannot Entirely Prevent Wrong-Site Surgery

By HospiMedica staff writers
Posted on 15 May 2006
A 20-year review of wrong-site surgery procedures reported to a large malpractice insurer shows that current protocols would prevent only about 60% of cases.

Researchers from the Brigham and Women's Hospital (Boston, MA, USA) and the Harvard School of Public Health (Boston, MA, USA) looked at records between 1985 and 2004 of Controlled Risk Insurance Corporation (CRICO, Cambridge, MA, USA), which provides liability insurance to a third of Massachusetts physicians and about 30 hospitals. More...
The researchers found 25 non-spinal cases of wrong-site surgery, out of 1,426,901 inpatient and 1,399,466 outpatient surgical procedures performed during the study period. This represents an estimated incidence rate of one in 112,994 operations for non-spinal wrong-site surgery.

Of the 25 non-spinal cases, medical records were available for review in 13. Of these, only one of the cases had results regarded as both permanent and significant, while the remainder were temporary and ranged from slight scarring to a moderately or severely delayed recovery. The results were published in the April 2006 issue of Archives of Surgery.

Publicity surrounding wrong-site surgery cases has led the U.S. Joint Commission on Accreditation of Healthcare Organizations (JCAHO) to develop a protocol that all accredited hospitals must now implement. The minimum requirements of the protocol are preoperative verification of both the surgical site and the patient, marking the surgical site on the patient, and the institution of a time out in the operating room for final confirmation. The researchers stated that implementation of the JCAHO protocol would not have prevented five of the cases (38%) but "under optimal conditions” it might have prevented the other eight.

"Wrong-site surgery is rare but shocking to the public, said Dr. Mary Kwaan and colleagues. "However, at the rate detected in this study, a wrong-site surgery serious enough to result in a report to risk managers or a lawsuit would occur at a single large hospital about once every five to 10 years.”



Related Links:
Brigham and Women's Hospital
Harvard School of Public Health

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.